Meixiang Yu

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

Eric M. Reiman, Kewei Chen, Xiaofen Liu et al. · Proceedings of the National Academy of Sciences · 2009 · 791 citations · Full text

Fibrillar Amyloid-β Burden, Neurochemical Biomarkers, Geriatric Neurology +21

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.

Rosario Sánchez‐Pernaute, Andrew Ferree, Oliver Cooper et al. · Journal of Neuroinflammation · 2004 · 205 citations · Full text

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis

Jari Tiihonen, Jyrki T. Kuikka, Pirkko Räsänen et al. · Molecular Psychiatry · 1997 · 162 citations

Neuropsychology, Generalized Anxiety Disorder, Psychiatry +14

Regional Effects of Donepezil and Rivastigmine on Cortical Acetylcholinesterase Activity in Alzheimer’s Disease

Valtteri Kaasinen, Kjell Någren, Tarja Järvenpää et al. · Journal of Clinical Psychopharmacology · 2002 · 139 citations

Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons

Jessica B. Langbaum, Kewei Chen, Lenore J. Launer et al. · Neurobiology of Aging · 2011 · 132 citations · Full text

Metabolic Syndrome, Hypertension, Alzheimer's Disease +11